Zoetis (ZTS) Stock Analysis: AI Score & Alternative Data
ZTS alt-data: headcount climbing, job postings lagging
Is Zoetis a buy right now? The alternative data says hold. This ZTS stock analysis is built on the 25+ alternative data signals AltIndex tracks on Zoetis every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 56/100: a Hold. The stock trades at $75.13 with a $32B market cap.
The bullish side of the 90-day ledger: headcount (according to LinkedIn) up 10.9% to 14K employees. The drag: job postings down 19.1% to 174 open roles, and just 58% of employees report a positive business outlook. That tension is what keeps the score mid-range.
ZTS’s broader alt-data profile also covers web traffic (282K monthly visits), quarterly revenue ($2.3B), Facebook followers (96K), and sentiment (100/100). Every signal links to its own page with full history, the ZTS technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on ZTS is just below.
Zoetis AI Stock Analysis
Zoetis Inc. is a global animal health company that specializes in medicines, vaccines, and diagnostic products for both livestock and companion animals. It operates in multiple segments including livestock, companion animals, cattle, swine, poultry, fish, and sheep.
Analysis generated July 1, 2026.
Recent Zoetis Stock Alerts
|
Zoetis | July 3 Gilbert Cisneros (member of U.S. congress) is buying shares |
|
Zoetis | July 3 Reddit mentions are up by 641% in the last 24h. |
|
Zoetis | July 1 Job postings are up by 32.6% in the last couple of days. |
|
Zoetis | June 23 Job postings are up by 58.7% in the last couple of days. |
Zoetis Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 282K | 1.7% | |
| Job Posts | 174 | 19.1% | |
| LinkedIn Employees | 14K | 10.9% | |
| Employee Recommend | 72 | 1.4% | |
| Business Outlook | 58 | 3.3% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 9 | 350.0% | |
| Stocktwits Mentions | 6 | 50.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 4K | 9.9% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 16K | 0% | |
| Instagram Followers | 63K | 2.3% | |
| Youtube Subscribers | 7K | 1.4% | |
| Facebook Followers | 96K | 0.8% | |
| Facebook Engagement | 475 | 3.7% |
About Zoetis (ZTS)
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming.
| Price | $75.13 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $32B |
| Year Range | $72 – $155 |
| Dividend Yield | 0% |
| PE Ratio | 12.4 |
| Analyst Rating | 38% buy |
| Industry | Pet Care |
Latest Zoetis News
View more → |
Zoetis Deadline: ZTS Investors with Losses in Excess of $100K Have Opportunity to Lead Zoetis Inc. Securities Fraud LawsuitJuly 10 - PRNewswire |
ZOETIS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTSJuly 10 - GlobeNewswire |
|
 |
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJuly 10 - PRNewswire |
Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors to Contact the Firm Before the July 27th Lead Plaintiff DeadlineJuly 10 - GlobeNewswire |
|
DEADLINE ALERT for CALX, AVAV, ZTS, LCID: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class ActionsJuly 9 - GlobeNewswire |
|
Zoetis Earnings & Financial Performance
View all earnings →Zoetis Insider Trading Activity
View all →| Bisaro Paul filed to sell 27,862 shares at $0.0. May 13 '26 |
| DAMELIO FRANK A filed to sell 21,458 shares at $0.0. May 13 '26 |
| MCCALLISTER MICHAEL B filed to sell 24,524 shares at $0.0. May 11 '26 |
| PECK KRISTIN C filed to sell 112,137 shares at $0.0. Feb 17 '26 |
| PECK KRISTIN C filed to sell 101,337 shares at $0.0. Feb 17 '26 |
Zoetis Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gilbert Cisneros |
Jul 3, 26 | Buy | $8K+ |
| Ro Khanna |
Jun 11, 26 | Buy | $8K+ |
| Gilbert Cisneros |
Mar 10, 26 | Buy | $8K+ |
| Ro Khanna |
Nov 14, 25 | Buy | $8K+ |
| Rick Larsen |
Oct 17, 25 | Sell | $8K+ |
Stocks Similar to Zoetis
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
ChewyCHWY |
$20.28 2.9% | $9B | 44 |
 |
PetcoWOOF |
$2.60 1.6% | $731M | 43 |
 |
BARKBARK |
$9.39 2.2% | $84M | 30 |
 |
PetMedsPETS |
$1.99 1.7% | $42M | 36 |
Explore Zoetis Data
Frequently Asked Questions: Zoetis (ZTS)
Zoetis has an AltIndex AI Score of 56/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
56/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Zoetis (ZTS) stock is $75.13 with a market cap of $32B.
As of today, Zoetis’s PE (Price to Earnings) ratio is 12.4.
View the latest Zoetis insider transactions to see recent buying and selling activity by company executives and directors.
Check the Zoetis congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The ZTS stock price chart above shows Zoetis’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Zoetis technical analysis for RSI, moving averages, and more.
See the stocks similar to Zoetis section on this page for companies in the same industry ranked by market cap and AI Score.
